Document is current

Article History

Received: 11 January 2024

Accepted: 12 August 2024

First Online: 18 December 2024

Declarations

:

: Trials were conducted according to the Declaration of Helsinki/Good Clinical Practice Guidelines of the International Council for Harmonisation, and approved by the Institutional Review Board and/or Independent Ethics Committee of the investigational centers. Patients provided written informed consent.

: Not applicable.

: AD has received grant/research support from AbbVie, Bristol Myers Squibb, Celgene, Eli Lilly, GSK, Janssen, Novartis, Pfizer Inc, and UCB, and has been a consultant for AbbVie, Amgen, Aurinia, Bristol Myers Squibb, Celgene, Eli Lilly, GSK, Janssen, MoonLake, Novartis, Pfizer Inc, and UCB. SA has received grant/research support from Pfizer Inc and has been a consultant for, and participated in speaker bureaus for, AbbVie, Amgen, Eli Lilly, MSD, Novartis, Pfizer Inc, and UCB. JRC has received grant/research support from, and has been a consultant for, AbbVie, Amgen, Bristol Myers Squibb, CorEvitas, LLC (formerly Corrona, LLC), Eli Lilly, Janssen, Myriad, Novartis, Pfizer Inc, Sanofi, and UCB. BE-Z has received grant/research support from, and has been a consultant for, AbbVie, Amgen, Bristol Myers Squibb, Eli Lilly, Eva, Hekma, Janssen, MSD, New Bridge, Novartis, Pfizer Inc, Roche, Sandoz, Sanofi-Aventis, and Servier. MM has received grant/research support from AbbVie, Bristol Myers Squibb, and UCB, and has been a consultant for AbbVie, Eli Lilly, Novartis, Pfizer Inc, and UCB. CW, JW, SBM, IV, SM, DLF, AMD, LF, and AY are employees and stockholders of Pfizer Inc. RBML has been a consultant for AbbVie, Bristol Myers Squibb, Eli Lilly, Galapagos NV, Gilead Sciences, Janssen, Novartis, Pfizer Inc, and UCB.